How pharmaceutical companies are redefining strategies in a fast-changing regulatory and market landscape.

Exploring streamlined, transparent, and technology-driven solutions for drug registration and re-registration.

Finding the balance between affordable medicine and a viable pharmaceutical business model.

New technologies and standards transforming how drugs are labelled, tracked, and trusted.

Modernizing public purchasing systems to improve efficiency, transparency, and patient outcomes.

Building resilient local and contract manufacturing ecosystems in response to geopolitical and supply chain shifts.

The rise of dietary supplements: regulation, growth drivers, and evolving consumer expectations.

How digitalization and consolidation are reshaping wholesale and retail in the pharma supply chain.

Policy, ethics, and economics behind how essential medicines are selected and revised.

Protecting intellectual property in a global landscape — from patents to market exclusivity.

Harnessing digital technologies for smarter R&D, operations, and patient engagement.